arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences, Innovation

FT Pharma AI and Data Summit

Improving analysis and decision-making in R&D and beyond

Boston |
Speakers include:
Sarah Neville

Sarah Neville

Financial Times

Hannah Kuchler

Hannah Kuchler

Financial Times

Overview

It’s time to cut through the hype, dig deep and determine how artificial intelligence can be deployed effectively in pharma-biotech companies today. Then we can project how it will transform the industry in the new decade.

And let us not forget that AI is just a part of the ever-expanding data landscape in healthcare and life sciences. From the use of real world evidence in market access to concerns around who owns and controls patient data, a whole new spectrum of opportunities and risks is emerging.

Join us at the FT Pharma AI and Data Summit in Boston on October 1, 2020, for detailed insights on the latest data applications and how to make the most of them.

fallback
fallback Add to my Calendar 10/01/2020 08:00:0010/01/2020 17:00:00trueFT Pharma AI and Data SummitIt’s time to cut through the hype, dig deep and determine how artificial intelligence can be deployed effectively in pharma-biotech companies today. Then we can project how it will transform the industry in the new decade.And let us not forget that AI is just a part of the ever-expanding data landscape in healthcare and life sciences. From the use of real world evidence in market access to concerns around who owns and controls patient data, a whole new spectrum of opportunities and risks is emerging.Join us at the FT Pharma AI and Data Summit in Boston on October 1, 2020, for detailed insights on the latest data applications and how to make the most of them.FT-Pharma-AI-and-Data-Summitc4f211a3871aa3fa8be1fc514ff6cfc9MM/DD/YYYY

Register your interest

Agenda - 1st Oct

  • 8:00am
    Registration and Breakfast
  • 9:00am
    Opening Remarks
  • 9:05am
    Keynote: Adapting Pharma Company Culture to the Rise of AI

    Artificial intelligence has the potential to strengthen decision-making frameworks in pharma companies, but only if it is trusted. How difficult could it be for companies to adjust to the new reality? Have we been seduced by the idea that complex solutions are better than simple ones?

  • 9:35am
    Panel: Investing in Pharma's Data-Driven Future
    • What levels of investment in AI and data solutions are we seeing across the pharma industry? 
    • Who are the new players are coming into the pharma-healthcare ecosystem how are existing ones being forced to evolve?
    • What are some of the major strategic partnerships on AI in healthcare and how are they working out?
    • How can partners build trust on issues like patient data-sharing?
    • What regulatory challenges have been raised by the rise of AI and big data?
  • 10:20am
    Case Study: Saving Time and Money with AI Solutions

    Decision-makers need tangible examples of how AI can cut costs and speed up development. Hear how one drug developer has been adapting its clinical trial models to do just that.

  • 10:50am
    Refreshments
  • 11:15am
    Interview: Embracing AI as a Tool for Drug Discovery

    AI is much more than just a tool to increase the efficiency of clinical trials. Algorithms are now capable of designing new molecules based on pharmacological data. How does it work and what novel drug targets have been identified?

  • 11:45am
    Presentation: Advancing Personalized Medicine with AI Platforms

    The ability of AI platforms to interrogate a wide range of information in real-time will be key to the rise of personalized medicine. By analyzing patient data on things such as lifestyle and environment, it may be possible to determine better treatment plans.

  • 12:15pm
    Panel: Transforming Pharma R&D with AI and Data Analytics
    • What is the low-hanging fruit for AI in R&D?
    • In what ways could AI make trials cheaper, faster and more representative?
    • How are AI algorithms for clinical trial software validated?
    • How can errors that occur because of AI be isolated and addressed?
    • To what extent can AI enable clinical trials to be run without regular controls?
    • How do decision-makers avoid overreaching in terms of reliance on AI and data solutions?
  • 1:00pm
    Networking Lunch
  • 2:00pm
    Debate: Regulating AI in Pharma

    Regulatory frameworks for handling data need to evolve so that AI can establish itself as a trusted tool in R&D and other areas. But data is sensitive and is often controlled by more than one stakeholder. As analytical capabilities increase, what barriers could arise and how can they be overcome? 

  • 2:40pm
    Panel: Futurizing Pharma Workforces for the Age of AI
    • How do different job functions stand to benefit from advances in AI?
    • How will departments interact differently as AI and data applications become more advanced?
    • To what extent could AI and data solutions be interpreted as a threat to some jobs?
    • Why should AI and data professionals work in pharma over other industries?
    • How can AI and data-related skills be developed within companies? 
  • 3:25pm
    Keynote: Proving Value with AI and Real-World Evidence

    As data applications in hardware and software make RWE more readily available and reliable, how can companies make use it to prove value to payers and what barriers could they face?  

  • 3:55pm
    Closing Remarks
  • 4:00pm
    Drinks Reception

Chair and Moderators (2)

Sarah Neville

Sarah Neville

Global Pharmaceuticals Editor
Financial Times

Sarah Neville is Global Pharmaceuticals Editor of the Financial Times, a position she has held since 2016. She joined the Financial Times in 2001 and has held a series of senior roles, including Weekend News Editor, Analysis Editor, UK News Editor and Public Policy Editor. She began her career on local and regional newspapers, eventually becoming Political Editor of the Yorkshire Post. In 1995 she was awarded the Laurence Stern Fellowship on the Washington Post. 

Hannah Kuchler

Hannah Kuchler

US Pharma and Biotech Correspondent
Financial Times

Hannah Kuchler is US Pharma and Biotech Correspondent for the Financial Times, with a particular focus on how technology is transforming healthcare. For five years, Ms Kuchler served as FT’s San Francisco Correspondent where she covered Silicon Valley and technology with a focus on social media and cyber security. Ms Kuchler was previously a London-based UK news reporter for the FT, covering British politics and general UK news. Prior to this, she worked on the FT’s newsdesk, as Asia Correspondent for FT Tilt in Hong Kong, and covered US markets in New York.  Before joining the FT in 2009, Ms Kuchler was the Editor of The Oxford Student and won the Guardian’s Student Reporter of the Year award in 2008. She holds a Bachelor’s degree in Modern History from Balliol College, Oxford.

KEY QUESTIONS TO BE ADDRESSED

  • How is R&D being transformed by AI and data analytics?
  • To what extent will AI drive the future of personalised medicine?
  • What is the potential of AI and data analytics to support market access?
  • How can pharma companies be restructured to integrate new data applications?
  • How are AI and data analytics creating new opportunities for strategic partnerships?
fallback

HOW THIS EVENT IS DIFFERENT

Events often take a limited view of who in the pharma industry stands to benefit from AI and big data applications. We will approach the subject with a view to how it can transform the way companies do business at every step from laboratory to patient while recognising the challenge of bridging the gap between innovation and implementation.

fallback

WHO WILL BE THERE?

Wherever you work and whatever you do in healthcare and life sciences, this event will give you fresh perspectives on how to be part of pharma’s data-driven future.

fallback

SPONSORSHIP OPPORTUNITIES

  • Gain access to 200 senior executives and influential stakeholders from across the US;
  • Brand alignment with the FT and its unrivalled credibility;
  • Demonstrate thought-leadership on the latest data applications;
  • Benefit from sustained international visibility through our advertising and marketing campaigns

Joe Hames
Sector Head - Pharma and Healthcare
M: +44 791 329 2038
E: joe.hames@ft.com

fallback

PRESENTED BY (1)

The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community.

Venue

The Westin Boston Waterfront
The Westin Boston Waterfront
425 Summer St
Boston 02210

United States of America

Tel: +1 617-532-4600

fallback

CONTACT US

FT Live Delegate Services - EMEA
Delegate Booking and Registration Enquiries
Financial Times
Ciaran Larkin
Content Manager
Financial Times Live
Joe Hames
Sponsorship & Exhibitor Opportunities
Financial Times
Aoife Grimes
Campaign Marketing Manager
Financial Times